302 related articles for article (PubMed ID: 12829988)
21. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.
Brillanti S; Levantesi F; Masi L; Foli M; Bolondi L
Hepatology; 2000 Sep; 32(3):630-4. PubMed ID: 10960460
[TBL] [Abstract][Full Text] [Related]
22. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
Wirth S; Lang T; Gehring S; Gerner P
Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
[TBL] [Abstract][Full Text] [Related]
23. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
24. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
Andreone P; Cursaro C; Gramenzi A; Fiorino S; Di Giammarino L; Miniero R; D'Errico A; Grigioni WF; Gasbarrini G; Bernardi M
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):688-94. PubMed ID: 10730561
[TBL] [Abstract][Full Text] [Related]
25. Therapy of hepatitis C: alpha interferon and ribavirin.
Reichard O; Schvarcz R; Weiland O
Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
[TBL] [Abstract][Full Text] [Related]
26. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Gane EJ; Lo SK; Riordan SM; Portmann BC; Lau JY; Naoumov NV; Williams R
Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
[TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
Zuckerman E; Keren D; Slobodin G; Rosner I; Rozenbaum M; Toubi E; Sabo E; Tsykounov I; Naschitz JE; Yeshurun D
J Rheumatol; 2000 Sep; 27(9):2172-8. PubMed ID: 10990230
[TBL] [Abstract][Full Text] [Related]
28. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
[TBL] [Abstract][Full Text] [Related]
29. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
30. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
31. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.
Bodenheimer HC; Lindsay KL; Davis GL; Lewis JH; Thung SN; Seeff LB
Hepatology; 1997 Aug; 26(2):473-7. PubMed ID: 9252161
[TBL] [Abstract][Full Text] [Related]
32. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315
[TBL] [Abstract][Full Text] [Related]
34. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
Nephrologie; 2003; 24(2):89-94. PubMed ID: 12723514
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
36. [Experience with ronkoleukin and alfaferon combination in complex chronic hepatitis C treatment].
Popova LL; Suzdal'tsev AA; Konstantinov DIu; Golik OO; Vasil'ev SIu
Eksp Klin Gastroenterol; 2011; (6):102-7. PubMed ID: 22168088
[TBL] [Abstract][Full Text] [Related]
37. Antiviral therapy for chronic hepatitis C viral infection.
Sherlock S
J Hepatol; 1995; 23 Suppl 2():3-7. PubMed ID: 8720286
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
Hamidah A; Yong JF; Zulkifli HI; Jamal R
Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
[TBL] [Abstract][Full Text] [Related]
39. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
Tinè F; Graviano D; Giannuoli G; Madonia S; Malizia G; Patti S; Fasola S; Cottone M; D'Amico G;
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1113-23. PubMed ID: 20848397
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of patients with chronic hepatitis C who have not been previously treated].
Marcellin P; Boyer N
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B194-201. PubMed ID: 12180288
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
